Abstract:Transcatheter arterial chemoembolization (TACE) is the first-line therapy for hepatocellular carcinoma (HCC). However, the exacerbated hypoxia microenvironment induces tumor relapse and metastasis post-TACE. Here, temperature-sensitive block polymer complexed with polyphosphate-cisplatin (Pt-P@PND) was prepared for the enhancement of tumor artery embolization by coagulation activation. After supra-selective infusion into the tumor vessels, Pt-P@PND nanogels performed efficient embolization of tumor arteries by sol-gel transition at body temperature. Meanwhile, coagulation cascade was evoked to form blood clots in the peripheral arteries inaccessible to the nanogels by released PolyP. The blood clots-filled hydrogel networks composed of gel and clots showed a denser structure and higher modulus, thereby achieving long-term embolization of all levels of tumor arteries. Pt-P@PND nanogels efficiently inhibited tumor growth and reduced the expression of HIF-1α, VEGF, CD31, and MMP-9 on VX2 tumor-bearing rabbit model. The released Nitro-Pt stimulated the immunogenic cell death of tumor cells, thus enhancing the antitumor immune response to suppress tumor relapse and metastasis post-TACE. It is hoped that Pt-P@PND nanogels can be developed as a promising embolic agent with procoagulant activity for enhancing the antitumor immune response through a combination of embolism, coagulation, and chemotherapy. STATEMENT OF SIGNIFICANCE: Clinical embolic agents, such as Lipiodol and polyvinyl alcohol (PVA) microspheres, are limited by their rapid elimination or larger size, thus lead to incomplete embolization of trans-catheter arterial chemoembolization (TACE). Herein, temperature-sensitive Pt-P@PND nanogels were developed to achieve long-term embolization of all levels of tumor arteries by gel/clot generation. The released Nitro-Pt induced immunogenic cell death in tumor cells, which improved the antitumor immune microenvironment by the maturation of DCs and lymphocytic infiltration. Pt-P@PND nanogels successfully inhibited tumor growth and activated an antitumor immune response to curb the recurrence and metastasis of residual tumor cells both in VX2 tumor-bearing rabbit model and 4T1 tumor-bearing mouse model. These findings suggested that Pt-P@PND could be developed as an ideal embolic agent for clinical TACE treatment.

Targeting Study of Gelatin Adsorbed Clodronate in Reticuloendothelial System and Its Potential Application in Immune Thrombocytopenic Purpura of Rat Model

[Experimental Study for Thrombocytopenic Purpura Therapy by Targeting Macrophages in Liver and Spleen].

Nanoparticles Camouflaged in Platelet Membrane Coating As an Antibody Decoy for the Treatment of Immune Thrombocytopenia.

Vincristine-loaded platelets coated with anti-CD41 mAbs: a new macrophage targeting proposal for the treatment of immune thrombocytopenia.

Targeting Neutrophil Extracellular Trap Accumulation under Flow in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura

Enhancing regulatory T-cell function via inhibition of high mobility group box 1 protein signaling in immune thrombocytopenia

Platelet Desialylation: A Novel Mechanism of Fc-Independent Platelet Clearance and A Potential Diagnostic Biomarker and Therapeutic Target in Immune Thrombocytopenia

Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles

Time-dependent biodistribution profiles and reaction of polyethylene glycol-coated iron oxide nanoclusters in the spleen after intravenous injection in the mice

Glomerulus-Targeted ROS-Responsive Polymeric Nanoparticles for Effective Membranous Nephropathy Therapy

Temperature-sensitive nanogels combined with polyphosphate and cisplatin for the enhancement of tumor artery embolization by coagulation activation

CCL4-mediated Targeting of Spleen Tyrosine Kinase (syk) Inhibitor Using Nanoparticles Alleviates Inflammatory Bowel Disease

Clodronate-liposomes Aggravate Irradiation-Induced Myelosuppression by Promoting Myeloid Differentiation

Inflammation-Targeted Delivery of Celastrol Via Neutrophil Membrane-Coated Nanoparticles in the Management of Acute Pancreatitis.

Platelet–neutrophil Hybrid Membrane-Coated Gelatin Nanoparticles for Enhanced Targeting Ability and Intelligent Release in the Treatment of Non-Alcoholic Steatohepatitis

Long-circulating Nanoparticles As Passive Targeting Nanocarriers for the Treatment of Thrombosis.

Human Serum Albumin-enriched Clopidogrel Bisulfate Nanoparticle Alleviates Cerebral Ischemia–Reperfusion Injury in Rats

474P Evaluation of Gelatinase-Responsive Copolymeric Nanoparticles Targeting PD-1 and TGF-β Pathways for Treating Immune-Resistant Tumor

Targeted therapies of inflammatory diseases with intracellularly gelated macrophages in mice and rats

Liposomal sodium clodronate mitigates radiation-induced lung injury through macrophage depletion

Abstract 246: Glycosylation Engineered Platelet Membrane Coated Nanoparticle For Targeted Inhibition Of Vascular Restenosis